Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2750 of 3284 entries
View as:

Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00629239 Org: User:
Start: 01/31/08 End: 08/31/08 Due: 08/31/09

Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02583477 Org: User:
Start: 03/25/16 End: 07/09/18 Due: 07/09/19

Observational Study To Evaluate Statins Patterns Of Use In Spain

Phase: N/A Priority: Normal
NCT ID: NCT01023503 Org: User:
Start: 03/31/11 End: 07/31/12 Due: 07/31/13

Risk of Uncomplicated Peptic Ulcer in the General Population

Phase: N/A Priority: Normal
NCT ID: NCT01888588 Org: User:
Start: 09/30/12 End: 05/31/13 Due: 05/31/14

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

Phase: N/A Priority: Normal
NCT ID: NCT02547935 Org: User:
Start: 09/21/15 End: 05/18/18 Due: 05/18/19

Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00750425 Org: User:
Start: 08/31/08 End: 01/31/11 Due: 01/31/12

A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate

Phase: N/A Priority: Normal
NCT ID: NCT03740373 Org: User:
Start: 09/04/18 End: 10/11/18 Due: 10/11/19

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT06137144 Org: User:
Start: 01/23/24 End: 05/08/26 Due: 05/08/27

A Bioequivalence Study to Compare VIMOVO Manufactured at AstraZenca AB to VIMOVO Manufactured by Patheon Pharmaceuticals and Marketed Enteric-coated Naproxen Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01331993 Org: User:
Start: 09/30/11 End: 10/31/11 Due: 10/31/12

First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03798535 Org: User:
Start: 12/19/18 End: 07/16/24 Due: 07/16/25

Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

Phase: N/A Priority: Normal
NCT ID: NCT06406400 Org: User:
Start: 05/13/24 End: 07/31/24 Due: 07/31/25

The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly

Phase: N/A Priority: Normal
NCT ID: NCT01370577 Org: User:
Start: 07/31/11 End: 11/30/12 Due: 11/30/13

Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00673231 Org: User:
Start: 04/30/08 End: 01/31/11 Due: 01/31/12

A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen

Phase: N/A Priority: Normal
NCT ID: NCT04187508 Org: User:
Start: 02/06/20 End: 11/10/21 Due: 11/10/22

AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02511795 Org: User:
Start: 08/06/15 End: 10/16/19 Due: 10/16/20

Study to Evaluate Safety, Tolerability and Pharmacokinetics (PK) (Including Food Effect) of Oral Doses of AZD5847 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01037725 Org: User:
Start: 12/31/09 End: 04/30/10 Due: 04/30/11

An Ophthalmic Safety Study in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06767462 Org: User:
Start: 03/04/25 End: 07/06/27 Due: 07/06/28

Phase II Efficacy Study of AZD6244 in Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00514761 Org: User:
Start: 09/30/06 End: 07/31/08 Due: 07/31/09

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03732820 Org: User:
Start: 10/31/18 End: 04/27/26 Due: 04/27/27

Does Tailored Education in Asthma Care Help Improve Patient Satisfaction, Adherence, and Quality of Life (TEACH) Trial

Phase: N/A Priority: Normal
NCT ID: NCT00687310 Org: User:
Start: 12/31/05 End: 01/31/07 Due: 01/31/08

Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)

Phase: N/A Priority: Normal
NCT ID: NCT00653965 Org: User:
Start: 05/31/03 End: 02/28/05 Due: 02/28/06

Asia Pacific and Russia Diagnostic Study for EGFR Testing

Phase: N/A Priority: Normal
NCT ID: NCT01788163 Org: User:
Start: 02/27/13 End: 06/20/16 Due: 06/20/17

A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00556023 Org: User:
Start: 06/30/08 End: 08/31/11 Due: 08/31/12

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Phase: N/A Priority: Normal
NCT ID: NCT00681759 Org: User:
Start: 01/31/08 End: 09/30/08 Due: 09/30/09

CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

Phase: N/A Priority: Normal
NCT ID: NCT06927648 Org: User:
Start: 12/31/25 End: 02/28/30 Due: 02/28/31